ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1286 Ergebnisse für "combination" unter ETH Entrepreneurship
Photochemical degradation of iron(III)-citrate/citric acid aerosol ...
... aerosol quantified with the combination of three complementary experimental techniques and a kinetic ... Photochemical degradation of iron(III)-citrate/citric acid aerosol quantified with the combination ... Photochemical degradation of iron(III)-citrate/citric acid aerosol quantified with the combination ... Photochemical degradation of iron(III)-citrate/citric acid aerosol quantified with the combination ...
Regulating the behavioural patterns of urban dwellers: The combinat...
... Regulating the behavioural patterns of urban dwellers: The combination of different mobility ... Regulating the behavioural patterns of urban dwellers: The combination of different mobility ... Regulating the behavioural patterns of urban dwellers: The combination of different mobility ... Regulating the behavioural patterns of urban dwellers: The combination of different mobility ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
1178 Ergebnisse für "combination" unter University of Zurich
Road network selection using an extended stroke-mesh combination al...
... combination algorithm. In: 16th ICA Workshop on Generalisation and Multiple Representation, Dresden, Germany ... Road network selection using an extended stroke-mesh combination algorithm - Zurich Open Repository ... Road network selection using an extended stroke-mesh combination algorithm - Zurich Open Repository ... Road network selection using an extended stroke-mesh combination algorithm - Zurich Open Repository ...
Combination of IAP antagonist and IFNγ activates novel caspase-10- ...
... Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death ... Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death ... Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death ... Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
1749 Ergebnisse für "combination" unter Somagenetix
Comparative pharmacokinetic estimates of drospirenone alone and in ...
... Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl ... determine the pharmacokinetics (PK) of drospirenone (DRSP), alone versus in combination with ethinyl ... Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl ... Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl ... Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl ...
Spelling normalisation of Late Modern English: comparison and combi...
... Schneider, Gerold (2020). Spelling normalisation of Late Modern English: comparison and combination ... Spelling normalisation of Late Modern English: comparison and combination of VARD and character ... Spelling normalisation of Late Modern English: comparison and combination of VARD and character ... Spelling normalisation of Late Modern English: comparison and combination of VARD and character ...
arcoris bio AG
8952 Schlieren, Wagistrasse 25
Kits and custom solutions for RNA FISH, Immunofluorescence, IHC, FACS and more.
arcoris bio AG
Wagistrasse 25
8952 Schlieren
1 Ergebnisse für "combination" unter arcoris bio AG
Immunofluorescence | arcoris bio AG
... High performance stainings with any combination of primary antibodies 3 - 5 plex Rapid and robust ... Immunofluorescence Kits High performance stainings with any combination of primary antibodies 3 - 5 plex Rapid and ...
rqmicro AG
8952 Schlieren, Brandstrasse 24
+41 44 512 51 51
rqmicro’s separation and detection technology for microbiological tests in the water and food industry delivers reliable, quantitative and cost-effective results in less than 2 hours.
rqmicro AG
Brandstrasse 24
8952 Schlieren
12 Ergebnisse für "combination" unter rqmicro AG
Products | rqmicro
... challenges of microbiological analysis. Our expertise lies in the combination of immunomagnetic separation ... accelerate the detection of pathogens from different types of aqueous sample matrices. In combination with ... expertise lies in the combination of immunomagnetic separation with different methods of analysis, in ... combination with the rqmicro instruments for manual or automated immunomagnetic separation, the analytical ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
36 Ergebnisse für "combination" unter Bio-Technopark Schlieren-Zürich
Kuros Biosciences receives US marketing clearance for intervertebra...
... advanced Fibrin-PTH product candidate for spinal fusion. The combination of KUR-113 with the TLIF cage will ... combination with autograft and/or allograft, under 510(k) number K183092. ... use with KUR-113, Kuros’s advanced Fibrin-PTH product candidate for spinal fusion. The combination of ... lumbar spine (L1 to S1) in combination with autograft and/or allograft, under 510(k) number K183092 ...
Molecular Partners Provides Additional Details on Clinical Studies ...
... , the efficacy and safety of MP0250 will be examined in combination with bortezomib (Velcade®) and ... Application (IND) for a phase 1b/2 trial of MP0250 in combination with osimertinib (Tagrisso®) in EGFR-mutated ... MP0250. In the first phase 2 study, the efficacy and safety of MP0250 will be examined in combination ... combination with osimertinib (Tagrisso ® ) in EGFR-mutated T790M-positive Non-Small Cell Lung Cancer (NSCLC ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
25 Ergebnisse für "combination" unter InSphero AG
... relevant 3D tumor models Test your drug of interest in combination with other therapeutics to identify ... (maximum response) and growth kinetics of 2 compounds alone and in combination, using size and ATP ... Test your drug of interest in combination with other therapeutics to identify pairs with synergistic ... kinetics of 2 compounds alone and in combination, using size and ATP (viability) endpoints over a 10 day ...
NA-DublinCopy-Correct.pdf
... - breast cancer spheroids after Docetaxel and/or Vinblastine in combination with irradiation treatment (GFP ... effects in combination with radiotherapy Tumour tissue response Normal tissue damage Anastasov et al ... - breast cancer spheroids after Docetaxel and/or Vinblastine in combination with irradiation treatment (GFP ... effects in combination with radiotherapy Tumour tissue response Normal tissue damage Anastasov et al ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
407 Ergebnisse für "combination" unter Roche Glycart AG
Cedex Analyzers
... analyzers of the Roche Cedex Analyzer family. The Cedex Bio Analyzers in combination with the Cedex HiRes ... Analyzers in combination with the Cedex HiRes Analyzer offer exceptional data reliability and near-automated ...
cobas® cfDNA Sample Preparation Kit
... preparation to isolate circulating cfDNA from plasma samples in combination with our cobas oncology assays ... isolate circulating cfDNA from plasma samples in combination with our cobas oncology assays, including ...
ImmunOs Therapeutics AG
http://immunostherapeutics.com/
8952 Schlieren, Wagistrasse 14
ImmunOs Therapeutics AG is a clinical-stage biotechnology company developing the next generation of novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and costimulatory agonists for cancer therapy. The company is actively discussing and exploring new strategic collaborations with leading global pharmaceutical companies.
ImmunOs Therapeutics AG
Wagistrasse 14
8952 Schlieren
14 Ergebnisse für "combination" unter ImmunOs Therapeutics AG
Pipeline | Immunos Therapeutics
... Background on Combination Immunotherapy: The immune system’s natural capacity to detect and destroy ... indications. It is designed as a potential first-line monotherapy and as a combination therapy to improve ... Pipeline | Immunos Therapeutics Background on Combination Immunotherapy: The immune system’s ... indications. It is designed as a potential first-line monotherapy and as a combination therapy to improve ...
The Next Generation Pipeline - Immunostherapy
... designed as a potential monotherapy and as a combination therapy to improve medical outcomes in non ... improved survival both as a monotherapy and in combination therapy. ImmunOs has successfully completed non ... designed as a potential monotherapy and as a combination therapy to improve medical outcomes in non ... improved survival both as a monotherapy and in combination therapy. ImmunOs has successfully completed non ...
Kuros Biosciences AG
8952 Schlieren, Wagistrasse 25
+41 (0)44 733 4747
Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
100 Ergebnisse für "combination" unter Kuros Biosciences AG
KUROS_n323597_v10A_11_Kuros_02_TSF_PIIb_Results_6m.doc
... and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced ... combination with standard of care (SOC) to SOC alone. The use of KUR-113 is designed to improve fracture union ... and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced ... combination with standard of care (SOC) to SOC alone. The use of KUR-113 is designed to improve fracture union ...
Establishing the new gold standard in bone regeneration
... model) Description Drug-biologic combination aimed to deliver targeted and controlled bone formation ... clinical experience in humans. Fibrin-PTH (KUR-113) is an investigational drug/biologic combination product ... model) Description Drug-biologic combination aimed to deliver targeted and controlled bone formation ... clinical experience in humans. Fibrin-PTH (KUR-113) is an investigational drug/biologic combination product ...
